Jane Street’s AgomAb Therapeutics NV AGMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$657K Buy
+59,208
New +$766K ﹤0.01% 7398
2026
Q2
– Sell
-12,794
Closed -$134K – 13821
2026
Q1
$134K Buy
+12,794
New +$181K ﹤0.01% 10469

Other funds holding AGMB

Jane Street's AGMB Position: Q3 2026 in Review

Jane Street opened a new position in AgomAb Therapeutics NV (AGMB) in Q3 2026: 59,208 shares worth $657K. The stake represents ﹤0.01% of the portfolio and ranks #7398 among its holdings. This is a return to the name: Jane Street previously reported a position in AGMB as recently as Q1 2026.

Jane Street first reported a position in AGMB in Q1 2026 and has held it in 2 quarters since. 25 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Jane Street held 59,208 shares of AgomAb Therapeutics NV worth $657K as of Q3 2026.
  • AgomAb Therapeutics NV was a new Jane Street position in Q3 2026.
  • AgomAb Therapeutics NV made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7398 holding.
  • Jane Street first reported a position in AgomAb Therapeutics NV in Q1 2026 and has held it in 2 quarters since.
  • 25 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.